Balyasny Asset Management
RLYB icon

Balyasny Asset Management’s Rallybio RLYB Stock Holding History

Balyasny Asset Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Buy
+376,573
New +$2.57M ﹤0.01% 1541

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Balyasny Asset Management's RLYB Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Rallybio (RLYB) in Q1 2026: 376,573 shares worth $3.38M. The stake represents ﹤0.01% of the portfolio and ranks #1541 among its holdings.

38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Balyasny Asset Management held 376,573 shares of Rallybio worth $3.38M as of Q1 2026.
  • Rallybio was a new Balyasny Asset Management position in Q1 2026.
  • Rallybio made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1541 holding.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.